Search by Drug Name or NDC

    NDC 36800-0914-02 Cold Max Nighttime 325; 2; 10; 5 mg/1; mg/1; mg/1; mg/1 Details

    Cold Max Nighttime 325; 2; 10; 5 mg/1; mg/1; mg/1; mg/1

    Cold Max Nighttime is a ORAL TABLET, COATED in the HUMAN OTC DRUG category. It is labeled and distributed by TopCo Associates LLC. The primary component is ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 36800-0914
    Product ID 36800-914_d0d6b66c-fe5b-3534-e053-2a95a90ac923
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Cold Max Nighttime
    Proprietary Name Suffix n/a
    Non-Proprietary Name ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, COATED
    Route ORAL
    Active Ingredient Strength 325; 2; 10; 5
    Active Ingredient Units mg/1; mg/1; mg/1; mg/1
    Substance Name ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name TopCo Associates LLC
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Rece
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 36800-0914-02 (36800091402)

    NDC Package Code 36800-914-02
    Billing NDC 36800091402
    Package 2 BLISTER PACK in 1 CARTON (36800-914-02) / 12 TABLET, COATED in 1 BLISTER PACK
    Marketing Start Date 2011-08-30
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL aa0d6762-b803-4630-8f74-780b7ea9acff Details

    Revised: 11/2021